Hope & Heroes bridges the gap between laboratory and clinical research, unlocking new possibilities in the fight against pediatric cancer.
Investment in cutting edge research related to biology, disease origins, and treatment bridges the gap between the laboratory and the clinic, transforming medical discoveries into improved health outcomes for childhood cancer patients everywhere.
Developmental Therapeutics Program
Provides the newest drugs for hard to treat diseases as well as access to the newest cancer therapies through enrollment in early-phase clinical trials.
Precision in Pediatrics
Research Program
Uses whole-genome analysis to customize treatment for each patient, allowing clinicians to identify the most effective and least invasive options.
Brain and Nervous System Tumor Laboratory
Focuses on understanding the biology of pediatric solid tumors, investigating tumor blood vessel growth, or angiogenesis, as a lens to illuminate the fundamental steps of tumor progression, metastasis, and resistance.
Mullen Foundation
International Initiative for Pediatric Nutrition (IIPAN)
Creates infrastructure and trains clinicians worldwide in order to provide access to the most effective, evidence-based nutritional care for pediatric illnesses in developing countries.
Fegel Foundation Initiative for Drug Delivery Innovation (IDDI)
Endowed chairs
We fund innovative research studies aimed at detection, prevention, and treatment of pediatric cancers and blood disorders. These vital studies would not be possible without philanthropy. Join us in our efforts to advance groundbreaking research that saves lives.
© 2023 Hopes & Heroes, All Rights Reserved. HIPPA Disclaimer | Privacy Policy
Hope & Heroes is an IRS 501(c)(3) nonprofit organization. Our EIN is 74-3066193.
Subscribe to our newsletter and stay up to date with all Hopes & Heroes news and events.
© 2023 Hopes & Heroes, All Rights Reserved. HIPPA Disclaimer | Privacy Policy
Hope & Heroes is an IRS 501(c)(3) nonprofit organization. Our EIN is 74-3066193.